Publications
Articles
HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4DQB1*0302 DAISY population
(2007). Diabetes, 56 (9), 2405-2409. , PMID: 17513705
Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS (2007). HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4DQB1*0302 DAISY population. Diabetes, 56 (9), 2405-2409.
Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays
(2007). Clin Immunol, 125 (2), 120-126. , PMID: 17904423, PMCID: PMC2104491
Liu E, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Liu E, Eisenbarth GS (2007). Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol, 125 (2), 120-126.
Prevelence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity
(2007). J Clin Endocrinol, 92 (1), 88-92. , PMID: 17062766
Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L
[Reprint] [PubMed]
[Citation View]
Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L (2007). Prevelence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol, 92 (1), 88-92.
Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with standard ELISA
(2007). J Rheumatol, 34 (4), 734-739. , PMID: 17407230
Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS (2007). Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with standard ELISA. J Rheumatol, 34 (4), 734-739.
A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1
(2007). Clin Immunol, 125 (2), 131-137. , PMID: 17825626, PMCID: PMC2080870
Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS
[Reprint] [PubMed]
[Citation View]
Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS (2007). A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol, 125 (2), 131-137.
Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus
(2007). J Leukoc Biol, 81 (3), 654-662. , PMID: 17151140
Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, Orban T.
[Reprint] [PubMed]
[Citation View]
Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, Orban T. (2007). Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol, 81 (3), 654-662.
Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype
(2006). Diabetes, 55 (5), 1265-1269. , PMID: 16644681
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR
[Reprint] [PubMed]
[Citation View]
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR (2006). Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes, 55 (5), 1265-1269.
Extreme genetic risk for type 1A diabetes
(2006). Proc Natl Acad Sci, 103 (38), 14074-14079. , PMID: 16966600, PMCID: PMC1563993
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS (2006). Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci, 103 (38), 14074-14079.
Omalizumab pretreatment decreases acute reactions following rush immunotherapy for ragweed-induced seasonal allergic rhinitis
(2006). J Allergy Clin Immunol, 117 (1), 134-140. , PMID: 16387596
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network
[Reprint] [PubMed]
[Citation View]
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network (2006). Omalizumab pretreatment decreases acute reactions following rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol, 117 (1), 134-140.
Immunotherapy with a ragweed–toll-like receptor 9 agonist vaccine for allergic rhinitis
(2006). New Engl J Med, 355 (14), 1445-1455. , PMID: 17021320
Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D, Immune Tolerance Network Group
[PubMed]
[Citation View]
Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D, Immune Tolerance Network Group (2006). Immunotherapy with a ragweed–toll-like receptor 9 agonist vaccine for allergic rhinitis. New Engl J Med, 355 (14), 1445-1455.
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses
(2006). Am J Transplant, 6 (9), 2121-2133. , PMID: 16796719
Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman Sl, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M
[Reprint] [PubMed]
[Citation View]
Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman Sl, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M (2006). Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant, 6 (9), 2121-2133.
Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study
(2006). Diabetes, 55 (9), 2588-2594. , PMID: 16936208
Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC
[Reprint] [PubMed]
[Citation View]
Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC (2006). Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes, 55 (9), 2588-2594.
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses
(2006). J Immunol Meth, 317 (1-2), 71-79. , PMID: 17070537, PMCID: PMC1934503
Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, Larché M, Durham SR, Francis JN
[Reprint] [PubMed]
[Citation View]
Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, Larché M, Durham SR, Francis JN (2006). The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Meth, 317 (1-2), 71-79.
International trial of the Edmonton protocol for islet transplantation
(2006). New Engl J Med, 355 (13), 1318-1330. , PMID: 17005949
Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR
[Reprint] [PubMed]
[Citation View]
Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR (2006). International trial of the Edmonton protocol for islet transplantation. New Engl J Med, 355 (13), 1318-1330.
A highly immunogenic trivalent T cell receptor peptide vaccine
(2005). Multiple Sclerosis, 11 (5), 552-561. , PMID: 16193893
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA
[Reprint] [PubMed]
[Citation View]
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA (2005). A highly immunogenic trivalent T cell receptor peptide vaccine. Multiple Sclerosis, 11 (5), 552-561.
Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells
(2005). J Exp Med, 201 (7), 1031-1036. , PMID: 15795239, PMCID: PMC2213133
Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F
[Reprint] [PubMed]
[Citation View]
Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F (2005). Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells. J Exp Med, 201 (7), 1031-1036.
Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells
(2005). Hum Immunol, 66 (7), 777-787. , PMID: 16112025
Danke NA, Koelle DM, Kwok WW
[Reprint] [PubMed]
[Citation View]
Danke NA, Koelle DM, Kwok WW (2005). Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells. Hum Immunol, 66 (7), 777-787.
Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro
(2005). Am J Transplant, 5 (3), 454-464. , PMID: 15707399
Game DS, Hernandez-Fuentes MP, Lechler RI
[Reprint] [PubMed]
[Citation View]
Game DS, Hernandez-Fuentes MP, Lechler RI (2005). Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant, 5 (3), 454-464.
Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane
(2005). J Immunol, 174 (6), 3204-3211. , PMID: 15749850
Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S
[Reprint] [PubMed]
[Citation View]
Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S (2005). Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane. J Immunol, 174 (6), 3204-3211.
Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2
(2005). J Infect Dis, 191 (2), 243-254. , PMID: 15609235, PMCID: PMC1255909
Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM
[Reprint] [PubMed]
[Citation View]
Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM (2005). Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2. J Infect Dis, 191 (2), 243-254.
Decreased Foxp3 levels in multiple sclerosis patients
(2005). J Neurosci Res, 81 (1), 45-52. , PMID: 15952173
Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA
[Reprint] [PubMed]
[Citation View]
Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA (2005). Decreased Foxp3 levels in multiple sclerosis patients. J Neurosci Res, 81 (1), 45-52.
Functional avidity directs T-cell fate in autoreactive CD4+ T-cells
(2005). Blood, 106 (8), 2798-2805. , PMID: 16030184, PMCID: PMC1895305
Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT
[Reprint] [PubMed]
[Citation View]
Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT (2005). Functional avidity directs T-cell fate in autoreactive CD4+ T-cells. Blood, 106 (8), 2798-2805.
Messenger RNA for FOXP3 in the urine of renal allograft recipients
(2005). New Engl J Med, 353 (22), 2342-2351. , PMID: 16319383
Muthukumar T, Dadhania D, Ding R, Snopkowski C, Nagvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M
[Reprint] [PubMed]
[Citation View]
Muthukumar T, Dadhania D, Ding R, Snopkowski C, Nagvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M (2005). Messenger RNA for FOXP3 in the urine of renal allograft recipients. New Engl J Med, 353 (22), 2342-2351.
Congruent effects of estrogen and T cell receptor peptide therapy on regulatory T cells in EAE and MS
(2005). Intl Rev Immunol, 24 (5-6), 447-477. , PMID: 16318990
Offner H, Vandenbark AA
[PubMed]
[Citation View]
Offner H, Vandenbark AA (2005). Congruent effects of estrogen and T cell receptor peptide therapy on regulatory T cells in EAE and MS. Intl Rev Immunol, 24 (5-6), 447-477.
TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4
(2005). Curr Drug Targets Inflamm Allergy, 4 (2), 217-229. , PMID: 15853744
Vandenbark AA
[PubMed]
[Citation View]
Vandenbark AA (2005). TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4. Curr Drug Targets Inflamm Allergy, 4 (2), 217-229.
Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
(2004). J Clin Endocrinol Metab, 89 (8), 3896-3902. , PMID: 15292324
Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in the Young
[Reprint] [PubMed]
[Citation View]
Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in the Young (2004). Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab, 89 (8), 3896-3902.
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up
(2004). Diabetes Care, 27 (6), 1399-1404. , PMID: 15161795
Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M, DAISY Study
[Reprint] [PubMed]
[Citation View]
Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M, DAISY Study (2004). Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care, 27 (6), 1399-1404.
Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation
(2004). Transplantation, 78 (1), 172-173. , PMID: 15257060
Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J
[Reprint] [PubMed]
[Citation View]
Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J (2004). Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation, 78 (1), 172-173.
Autoreactive T cells in healthy individuals
(2004). J Immunol, 172 (10), 5967-5972. , PMID: 15128778
Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW
[Reprint] [PubMed]
[Citation View]
Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW (2004). Autoreactive T cells in healthy individuals. J Immunol, 172 (10), 5967-5972.
Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells
(2004). Diabetes, 53 (4), 971-977. , PMID: 15047612
Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT
[Reprint] [PubMed]
[Citation View]
Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT (2004). Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells. Diabetes, 53 (4), 971-977.
Extensive replicative capacity of human central memory T cells
(2004). J Immunol, 172 (11), 6675-6683. , PMID: 15153483
Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH
[Reprint] [PubMed]
[Citation View]
Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH (2004). Extensive replicative capacity of human central memory T cells. J Immunol, 172 (11), 6675-6683.
In vivo biotinylation of the major histo-compatibility complex (MHC) class II/peptide complex by co-expression of BirA enzyme for the generation of MHC class II/tetramers
(2004). Hum Immunol, 65 (7), 692-699. , PMID: 15301857
Yang J, Jaramillo A, Shi R, Kwok WW, Mohanakumar T
[Reprint] [PubMed]
[Citation View]
Yang J, Jaramillo A, Shi R, Kwok WW, Mohanakumar T (2004). In vivo biotinylation of the major histo-compatibility complex (MHC) class II/peptide complex by co-expression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol, 65 (7), 692-699.
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts
(2003). Transplantation, 5 (8), 1307-1312. , PMID: 12717221
Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, Serur D, Seshan SV, Sharma VK, Kapur S, Suthanthiran M
[Reprint] [PubMed]
[Citation View]
Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, Serur D, Seshan SV, Sharma VK, Kapur S, Suthanthiran M (2003). CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation, 5 (8), 1307-1312.
Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients
(2003). Am J Transplant, 3 (6), 689-696. , PMID: 12780560
Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW
[Reprint] [PubMed]
[Citation View]
Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW (2003). Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant, 3 (6), 689-696.
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts
(2003). Transplantation, 75 (9), 1565-1570. , PMID: 12792516
Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, Hartono C, Serur D, Seshan SV, Volk HD, Reinke P, Kapur S, Suthanthiran M
[Reprint] [PubMed]
[Citation View]
Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, Hartono C, Serur D, Seshan SV, Volk HD, Reinke P, Kapur S, Suthanthiran M (2003). Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation, 75 (9), 1565-1570.
Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes
(2003). Methods, 29 (3), 282-288. , PMID: 12725793
Reijonen H, Kwok WW
[Reprint] [PubMed]
[Citation View]
Reijonen H, Kwok WW (2003). Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods, 29 (3), 282-288.
ICA512(IA-2) Epitope specific assays distinguish transient from diabetes associated autoantibodies
(2002). J Autoimmun, 18 (2), 191-196. , PMID: 11908951
Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F
[Reprint] [PubMed]
[Citation View]
Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F (2002). ICA512(IA-2) Epitope specific assays distinguish transient from diabetes associated autoantibodies. J Autoimmun, 18 (2), 191-196.
Evolution of the Enzyme-Linked Immunosorbent Spot Assay for post-transplant alloreactivity as a potentially useful immune monitoring tool
(2002). Am J Transplant, 2 (9), 857-866. , PMID: 12392292
Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ, Heeger PS
[Reprint] [PubMed]
[Citation View]
Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ, Heeger PS (2002). Evolution of the Enzyme-Linked Immunosorbent Spot Assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant, 2 (9), 857-866.
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine
(2002). Transplantation, 74 (7), 987-994. , PMID: 12394843
Ding R, Medeiros M, Dadhania D, Muthukumar T, Kracker D, Kong JM, Epstein SR, Sharma VK, Seshan SV, Li B, Suthanthiran M
[Reprint] [PubMed]
[Citation View]
Ding R, Medeiros M, Dadhania D, Muthukumar T, Kracker D, Kong JM, Epstein SR, Sharma VK, Seshan SV, Li B, Suthanthiran M (2002). Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation, 74 (7), 987-994.
Monitoring the patient off immunosuppression: Conceptual framework for a proposed tolerance assay study in liver transplant recipients
(2001). Transplantation, 72 (8), S13-S22. , PMID: 11888150
Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A
[Reprint] [PubMed]
[Citation View]
Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A (2001). Monitoring the patient off immunosuppression: Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation, 72 (8), S13-S22.
The Immune Tolerance Network: The "Holy Grail" comes to the clinic
(2000). J Am Soc Nephrol, 11 (11), 2141-2146. , PMID: 11053493
Bluestone JA, Matthews JB, Krensky AM
[Reprint] [PubMed]
[Citation View]
Bluestone JA, Matthews JB, Krensky AM (2000). The Immune Tolerance Network: The "Holy Grail" comes to the clinic. J Am Soc Nephrol, 11 (11), 2141-2146.
Review & Commentary
Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives
(2022). Front Immunol, 12 (791725). http://dx.doi.org/10.3389/fimmu.2021.791725, PMID: 35069574, PMCID: PMC8767096
Podestà MA, Sykes M.
[Reprint] [PubMed]
[Citation View]
Podestà MA, Sykes M. (2022). Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives. Front Immunol, 12 (791725).
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
(2021). Diabetes, 7 (4), 831-841. http://dx.doi.org/10.2337/db20-1185, PMID: 33741606, PMCID: PMC7980192
Linsley PS, Greenbaum CJ, GT Nepom
[Reprint] [PubMed]
[Citation View]
Linsley PS, Greenbaum CJ, GT Nepom (2021). Uncovering Pathways to Personalized Therapies in Type 1 Diabetes. Diabetes, 7 (4), 831-841.
Approaches to Establishing Tolerance in Immune Mediated Diseases
(2021). Front Immunol, 12, 744804. http://dx.doi.org/10.3389/fimmu.2021.744804
Huffaker M F, Sanda S, Chung S, St. Clair EW, Nepom GT, Smilek DE
[Reprint]
[Citation View]
Huffaker M F, Sanda S, Chung S, St. Clair EW, Nepom GT, Smilek DE (2021). Approaches to Establishing Tolerance in Immune Mediated Diseases. Front Immunol, 12, 744804.
Overview of oral tolerance induction for prevention of food allergy—Where are we now?
(2021). Allergy, 76 (9), 2684-2698. http://dx.doi.org/10.1111/all.14758, PMID: 33539570
Krawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G.
[PubMed]
[Citation View]
Krawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G. (2021). Overview of oral tolerance induction for prevention of food allergy—Where are we now?. Allergy, 76 (9), 2684-2698.
Food allergy
(2018). Nat Rev Dis Primers, 4 (4), 17098. http://dx.doi.org/10.1038/nrdp.2017.98, PMID: 29300005
Renz H, Allen KJ, Sicherer SH, Sampson HA, Lack G, Beyer K, Oettgen HC
[Reprint] [PubMed]
[Citation View]
Renz H, Allen KJ, Sicherer SH, Sampson HA, Lack G, Beyer K, Oettgen HC (2018). Food allergy. Nat Rev Dis Primers, 4 (4), 17098.
Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients.
(2018). Hum Immunol., 79 (5), 380-387. http://dx.doi.org/10.1016/j.humimm.2018.02.007, PMID: 29448053, PMCID: PMC5924709
Newell KA, Turka LA, Adams AB
[Reprint] [PubMed]
[Citation View]
Newell KA, Turka LA, Adams AB (2018). Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients.. Hum Immunol., 79 (5), 380-387.
Treatment for food allergy
(2018). J Allergy Clin Immunol, 141 (1), 1-9. http://dx.doi.org/10.1016/j.jaci.2017.11.004, PMID: 29307409
Burks AW, Sampson HA, Plaut M, Lack G, Akdis C
[Reprint] [PubMed]
[Citation View]
Burks AW, Sampson HA, Plaut M, Lack G, Akdis C (2018). Treatment for food allergy. J Allergy Clin Immunol, 141 (1), 1-9.
Mechanisms of food allergy
(2018). J Allergy Clin Immunol, 141 (1), 11-19. http://dx.doi.org/10.1016/j.jaci.2017.11.005, PMID: 29307410
Sampson HA, O'Mahony, L. Burks, AW. Plaut, M. Lack, Akdis CA
[Reprint] [PubMed]
[Citation View]
Sampson HA, O'Mahony, L. Burks, AW. Plaut, M. Lack, Akdis CA (2018). Mechanisms of food allergy. J Allergy Clin Immunol, 141 (1), 11-19.
Immune monitoring of transplant patients in transient mixed chimerism tolerance trials
(2018). Hum Immunol, 79 (5), 334-342. http://dx.doi.org/10.1016/j.humimm.2017.12.011, PMID: 29289741, PMCID: PMC5924718
Sykes M
[Reprint] [PubMed]
[Citation View]
Sykes M (2018). Immune monitoring of transplant patients in transient mixed chimerism tolerance trials. Hum Immunol, 79 (5), 334-342.